Autonomic Dysfunction Significantly Associated With Decreased Quality of Life in MS, NMOSD
September 23rd 2023Findings showed that autonomic symptom burden was slightly more severe in patients with multiple sclerosis (MS) compared with those with NMOSD, although the difference was not statistically significant.
Breast Cancer Risk Linked to Air Pollution Exposure
September 22nd 2023Data from 6 states—California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania—and 2 metropolitan areas—Atlanta, Georgia, and Detroit, Michigan—collected through the National Institutes of Health–AARP Diet and Health Study were used for the investigation.
Sociodemographic, Clinical Variables Impact Metabolic Control in Adolescents With T1D
Self-care adherence, family support and functioning, and school support also indirectly affected the relationship between sociodemographic and clinical variables and metabolic control, a study found.
DNA Index Most Effectively Identifies Patients With Hyperdiploid ALL
The measure of total DNA in leukemic cells as defined by a DNA index outperformed other criteria for identifying patients with hyperdiploid acute lymphoblastic leukemia (ALL) and favorable prognosis.
Racial Differences in Chemokine Expression May Contribute to Prostate Cancer Disparities
Researchers found that analyzing certain chemokine levels may help explain racial disparities in prostate cancer lethality, and that neutralizing such chemokines could potentially benefit prostate cancer treatment.
BNP Levels May Not Be Effective Prognostic Tool for Patients With Cardiogenic Shock Using VADs
September 22nd 2023While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist devices (VADs).
Salvage RT Shows Local Control in LBCL After CAR T-Cell Therapy Failure
Salvage radiation therapy (RT) showed efficacy in local control of relapsed or refractory large B-cell lymphoma (LBCL) following CD19-targeted chimeric antigen receptor (CAR) T-cell therapy failure.
Contributor: A Crisis in Public Health—Addressing the Exodus From Our Essential Workforce
September 22nd 2023Public health professionals are the backbone of our health system, and their contributions are vital to the well-being of our communities. As a society, we must value their work, provide the support they need, and ensure that public health remains a rewarding and viable career choice.
New CMS Models Target Transformation to Address Need for Health Equity
September 21st 2023"CMS cannot do this alone. We have to do this in partnership. So really thinking about providers and beneficiaries and how we do this together," Ellen Lukens, MPH, Center for Medicare and Medicaid Innovation, explained.
Panelists Discuss Insurance Coverage of Opill, OTC Contraceptives During KFF Webinar
September 21st 2023Laurie Sobel, the associate director for women’s health policy at KFF, moderated a panel discussion with Christine Gilroy, MD, MPH; Victoria Nichols, MPH; and Don Downing, RPh, about insurance coverage of FDA-approved Opill and other OTC contraceptives.
Tailored EHR Alerts Fail to Improve Acute HF Medication Prescription at Discharge
September 21st 2023A tailored electronic health record (EHR) alert system did not significantly increase the prescription of guideline-directed medical therapies (GDMT) at hospital discharge for patients with acute heart failure (AHF).